↓ Skip to main content

ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer

Overview of attention for article published in Frontiers in oncology, September 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ABTB2 Regulatory Variant as Predictor of Epirubicin-Based Neoadjuvant Chemotherapy in Luminal A Breast Cancer
Published in
Frontiers in oncology, September 2020
DOI 10.3389/fonc.2020.571517
Pubmed ID
Authors

Yajie Gong, Nanlin Hu, Li Ma, Wentong Li, Xiang Cheng, Yi Zhang, Ying Zhu, Yang Yang, Xiating Peng, Danyi Zou, Jianbo Tian, Lan Yang, Shufang Mei, Xiaoyang Wang, Chun-han Lo, Jiang Chang, Tieying Hou, Hong Zhang, Binghe Xu, Rong Zhong, Peng Yuan

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 23%
Student > Ph. D. Student 2 15%
Student > Master 2 15%
Student > Bachelor 1 8%
Student > Postgraduate 1 8%
Other 0 0%
Unknown 4 31%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 23%
Pharmacology, Toxicology and Pharmaceutical Science 2 15%
Nursing and Health Professions 1 8%
Agricultural and Biological Sciences 1 8%
Psychology 1 8%
Other 1 8%
Unknown 4 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 October 2020.
All research outputs
#22,999,918
of 25,643,886 outputs
Outputs from Frontiers in oncology
#16,224
of 22,758 outputs
Outputs of similar age
#373,888
of 432,333 outputs
Outputs of similar age from Frontiers in oncology
#429
of 675 outputs
Altmetric has tracked 25,643,886 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,758 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,333 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 675 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.